Cite
HARVARD Citation
Abd Elwakil, M. et al. (2019). Lung‐Targeted Rnai Therapeutics: Lung‐Endothelium‐Targeted Nanoparticles Based on a pH‐Sensitive Lipid and the GALA Peptide Enable Robust Gene Silencing and the Regression of Metastatic Lung Cancer (Adv. Funct. Mater. 18/2019). Advanced functional materials. p. n/a. [Online].